September 4th, 2013
New Dual Biomarker Test Could Speed Rule-Out of MI in the ED
Larry Husten, PHD
A new study suggests that patients with suspected ACS and negative troponin and copeptin results at admission can safely be discharged if the clinical assessment is consistent with that decision.
May 24th, 2011
Copeptin May Help Predict CV Death in Elderly HF Patients
Larry Husten, PHD
The biomarker copeptin, which is a surrogate marker of vasopressin, may help predict the risk for death in elderly heart failure patients, according to a new study in JAMA. Urban Alehagen and colleagues followed 470 elderly HF patients from 1996 through 2009, during which time there were 226 deaths from any cause and 146 deaths […]
NEJM Journal Watch — Recent Cardiology Articles- Transcatheter Valve Replacement for Severe Tricuspid Regurgitation
- Time in Blood Pressure Target Range and Outcomes in Hypertension: Real-World Data
- When to Start Anticoagulation After Ischemic Stroke in Patients with Atrial Fibrillation
- Aortic-Valve Replacement vs. Clinical Surveillance for Asymptomatic Severe Aortic Stenosis
- Secondary Hypertension in Young Adults